SCHEMBL5344475

SCHEMBL5344475

CC(C#N)N(C)S(=O)(=O)Cl

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.33
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11451017 0.74
SCHEMBL459653 0.73
Sulfuric Acid SCHEMBL27490439 0.67 DPP4 (0.37) DPP4TSHR
SCHEMBL109553 0.64
Water SCHEMBL11043959 0.64 TSHR (0.44) DPP4TSHR
SCHEMBL9343649 0.64 TSHR (0.44) DPP4TSHR
SCHEMBL10897289 0.64
SCHEMBL8698477 0.64
SCHEMBL9782111 0.62 DPP4 (0.34) DPP4
SCHEMBL2559690 0.62 TSHR (0.41) DPP4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7232926-B2 Method for the production of sulphamic acid halogenides BASF AKTIENGESELLSCHAFT (DE) 2007-06-19 US disclosed
US-20050159622-A1 Method for the production of sulphamic acid halogenides BASF AKTIENGESELLSCHAFT (DE) 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159622-A1 Method for the production of sulphamic acid halogenides AS3MT, ARSA, SRM DPP4 1223/4885TSHR 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.